Trade Raysearch Laboratories B - RAYb CFD
Add to favourite- Summary
- Historical Data
| Spread | 2.1 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.01705% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.005172% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | SEK | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Sweden | ||||||||
| Commission on trade | 0% |
| Prev. Close | 229.2 |
| Open | 230.2 |
| 1-Year Change | 98.28% |
| Day's Range | 227.7 - 233.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | 232.2 | 4.5 | 1.98% | 227.7 | 234.2 | 226.7 |
| Apr 22, 2025 | 229.2 | -0.5 | -0.22% | 229.7 | 232.2 | 219.7 |
| Apr 17, 2025 | 232.7 | 1.0 | 0.43% | 231.7 | 235.2 | 229.2 |
| Apr 16, 2025 | 237.7 | 6.0 | 2.59% | 231.7 | 238.7 | 228.2 |
| Apr 15, 2025 | 234.7 | 12.0 | 5.39% | 222.7 | 236.7 | 219.7 |
| Apr 14, 2025 | 224.2 | 3.0 | 1.36% | 221.2 | 225.2 | 214.2 |
| Apr 11, 2025 | 216.2 | 0.0 | 0.00% | 216.2 | 218.2 | 208.2 |
| Apr 10, 2025 | 215.7 | -9.5 | -4.22% | 225.2 | 229.7 | 211.7 |
| Apr 9, 2025 | 210.7 | 0.5 | 0.24% | 210.2 | 213.2 | 204.7 |
| Apr 8, 2025 | 216.2 | 10.5 | 5.10% | 205.7 | 217.7 | 205.2 |
| Apr 7, 2025 | 204.2 | 11.6 | 6.02% | 192.6 | 216.7 | 192.2 |
| Apr 4, 2025 | 209.7 | -12.5 | -5.63% | 222.2 | 223.7 | 203.2 |
| Apr 3, 2025 | 223.2 | 7.0 | 3.24% | 216.2 | 227.2 | 216.2 |
| Apr 2, 2025 | 224.2 | -3.5 | -1.54% | 227.7 | 228.2 | 221.7 |
| Apr 1, 2025 | 225.2 | 2.0 | 0.90% | 223.2 | 230.2 | 222.7 |
| Mar 31, 2025 | 224.7 | 0.5 | 0.22% | 224.2 | 227.7 | 219.7 |
| Mar 28, 2025 | 225.7 | -0.5 | -0.22% | 226.2 | 236.2 | 225.2 |
| Mar 27, 2025 | 231.7 | 5.5 | 2.43% | 226.2 | 231.7 | 219.2 |
| Mar 26, 2025 | 226.2 | -12.0 | -5.04% | 238.2 | 241.2 | 224.7 |
| Mar 25, 2025 | 235.7 | 5.5 | 2.39% | 230.2 | 236.2 | 228.2 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Raysearch Company profile
About RaySearch Laboratories AB (publ)
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, RaySearch Laboratories AB (publ) revenues decreased 2% to SEK641.1M. Net loss increased from SEK9.1M to SEK47.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development expenditure - B increase from SEK41K to SEK62.4M (expense), Amortization in R&D increase of 22% to SEK166.7M (expense).
Equity composition
June 2003: Capital restructuring, name changed from Taurus Petroleum AB to RaySearch and FY end date changed from Aug to Dec. Reverse stock split in the ratio 20:1, par value increased to SEK1.50 and a new issue of 4,212,607 A-Shares and 5,877,633 B-Shares. 06/2008, 3-for-1 stock split.
| Industry: | Medical Software & Technology Services |
Eugeniavägen 18C
STOCKHOLM
STOCKHOLM 104 30
SE
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com